BSGM Stock Overview
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
BioSig Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.30 |
| 52 Week High | US$16.50 |
| 52 Week Low | US$0.26 |
| Beta | 1.2 |
| 1 Month Change | 176.60% |
| 3 Month Change | -40.37% |
| 1 Year Change | -89.34% |
| 3 Year Change | -96.47% |
| 5 Year Change | -98.06% |
| Change since IPO | -98.38% |
Recent News & Updates
Recent updates
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now
Dec 12
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
Dec 14BioSig in acquisition pact with San Antonio Hospital for cardiac signal system
Oct 07BioSig: No Changes To Hold Thesis Following Q2 Earnings
Sep 08BioSig signs purchase deal with Kansas City's Overland Park Regional hospital
Jul 07BioSig: PURE EP Economics Trade Exhausted
Jun 14Companies Like BioSig Technologies (NASDAQ:BSGM) Could Be Quite Risky
Mar 22Here's Why BioSig Technologies (NASDAQ:BSGM) Must Use Its Cash Wisely
Dec 02We Think BioSig Technologies (NASDAQ:BSGM) Needs To Drive Business Growth Carefully
Jun 29Will BioSig Technologies (NASDAQ:BSGM) Spend Its Cash Wisely?
Mar 17Shareholder Returns
| BSGM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -15.6% | 1.8% | 1.2% |
| 1Y | -89.3% | -0.5% | 24.9% |
Price Volatility
| BSGM volatility | |
|---|---|
| BSGM Average Weekly Movement | 44.6% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 4 | n/a | www.biosig.com |
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias.
BioSig Technologies, Inc. Fundamentals Summary
| BSGM fundamental statistics | |
|---|---|
| Market cap | US$14.56m |
| Earnings (TTM) | -US$29.05m |
| Revenue (TTM) | US$18.00k |
808.8x
P/S Ratio-0.5x
P/E RatioIs BSGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSGM income statement (TTM) | |
|---|---|
| Revenue | US$18.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$18.00k |
| Other Expenses | US$29.07m |
| Earnings | -US$29.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.59 |
| Gross Margin | 100.00% |
| Net Profit Margin | -161,388.89% |
| Debt/Equity Ratio | 0% |
How did BSGM perform over the long term?
See historical performance and comparison